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A small number of conserved canonical single nucle-
otide polymorphisms (canSNP) that deﬁ  ne major phyloge-
netic branches for Bacillus anthracis were used to place 
a Sverdlovsk patient’s B. anthracis genotype into 1 of 12 
subgroups. Reconstruction of the pagA gene also showed a 
unique SNP that deﬁ  nes a new lineage for B. anthracis.
T
he 1979 accidental release of Bacillus anthracis spores 
in the northeastern quadrant of Sverdlovsk (today’s 
Ekaterinburg) in the former Soviet Union resulted in a 
relatively large-scale incident of inhalation anthrax (1). 
Histologic examinations of formalin-ﬁ  xed,  parafﬁ  n-em-
bedded tissue samples from patients affected by this inci-
dent showed pathologic changes (2). Parafﬁ  n-embedded 
material from 11 of these patients was also subjected to 
molecular DNA analysis to demonstrate the presence of B. 
anthracis plasmid markers (3). These tissue samples ap-
peared to contain 3–4 allelic variants of B. anthracis, based 
on a single variable-number tandem repeat (VNTR) marker 
(vrrA), which suggests that the material contained multiple 
strains of this species (4).
An early global comparison of the entire pagA gene 
sequence from 26 diverse B. anthracis isolates and a single 
nucleotide polymorphism (SNP)–rich region (307 bp) of 
the samples from Sverdlovsk found 7 SNPs in this gene 
(5). Two of these SNPs were unique to 3 of the Sverdlovsk 
samples. However, the distribution of the remaining 5 SNPs 
separated the 26 diverse isolates and the remaining Sverd-
lovsk samples into clusters that were consistent with diver-
sity groups previously described by ampliﬁ  ed fragment–
length polymorphism (AFLP) analysis of a larger subset of 
isolates (6). The AFLP analysis had separated a collection 
of 78 isolates into 5 diversity groups. Although only 307 bp 
of the Sverdlovsk tissue samples were sequenced, a single 
SNP (pagA SNP 3602) placed 7 of 10 Sverdlovsk tissue 
samples into a large diversity group called western North 
America (WNA) (5).
Recent comparisons among 5 B. anthracis whole ge-
nome sequences uncovered ≈3,000 SNPs, and the rigorous 
examination of ≈1,000 of these SNPs across 27 diverse iso-
lates demonstrated an extremely conserved clonal popula-
tion structure for this species (7,8). These results led to a 
genotyping method that uses a small number of canonical 
SNPs (canSNPs) to replace the analysis of ≈1,000 SNPs 
and still precisely deﬁ  nes key positions and branch points 
within the B. anthracis tree (9). This canSNP model was re-
cently tested against a large, diverse B. anthracis collection 
of 1,033 isolates (10). When all 1,033 isolates were evalu-
ated against a panel of 13 canSNPs, the results demonstrat-
ed that each B. anthracis isolate had 1 of only 12 different 
canSNP proﬁ  les. These analyses supported the notion that 
a single canSNP can be used to represent an entire genome 
when the genome being examined is as conserved as that of 
B. anthracis (7–9). This strategy was applied to the analysis 
of a Sverdlovsk sample that appears to represent a single 
diversity group previously recognized as WNA from pagA 
sequence analysis.
The Study
DNA was extracted by using QiaAmp DNA Mini Kits 
(QIAGEN, Valencia, CA, USA), following protocols recom-
mended for formalin-ﬁ  xed tissue samples. A Genomeplex 
Whole Genome Amplication Kit (Sigma, St. Louis, MO, 
USA) was used to preamplify the extracted DNA sample. 
Short DNA fragments were ampliﬁ  ed from these DNA sam-
ples by using the following primer sets: canSNP.A.Br.008 F: 
5′-GCCAAGATATTCGTGACATT-3′; canSNP.A.Br.008 
R: 5′-TTTGGACCAGGTTTCTGTATTT-3′; canSNP A.Br.
009 F: 5′-TGCGGAATATCGTTAAGTAAT-3′; canSNP 
A.Br.009R: 5′-TGGACGTGAATTAGGAAAAGT-3′ (for 
traditional PCR and sequencing); canSNP A.Br.008 F: 
5′-TCTAAGAAAGATTCGCAACTACGCTATAC-3′; 
canSNP A.Br.008 R: 5′-TGCATTCGCAACTACGCTATA
CGTTTTAGATG-3′; canSNP A.Br.009 F: 5′-TGCC
GGGGTTTCTACTGTGTATGTTGT-3′; canSNP A.Br.
009 R: 5′-TGGGTTAGGTATATTAACTGCGGATG
ATGC-3′ (for mass spectrometry base composition
analysis);  pagA 981 F: 5′-AATGAGGATCAATCCA
CACAG-3′; and pagA 981 R: 5′-ATTTAAACCCA
TTGTTTCAGC-3′. Traditional PCR ampliﬁ  cation schemes 
and DNA sequencing techniques were used for sequenc-
ing with an ABI 3100 DNA Analyzer (Applied Biosys-
tems, Foster City, CA, USA). The mass spectrometry re-
sequencing technique is described in detail elsewhere (11). 
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CACAGAATACTGATAGTCAAACGAGAACA-3′; Pag
SNP.981R 5′-GCACTTCTGCATTTCCATGTACTT-3′; 
probe 1: PagSNP.981T VIC 5′-ACAAGTAGGACt
CATAC-3′; and probe 2: PagSNP.981A 6FAM 5′-CAAG
TAGGACaCATACT-3′.
The Figure illustrates the relative positions of 3 
canSNPs along the branches of the canSNP-derived phy-
logenetic tree for the 1,033 B. anthracis isolates (10). The 
focus of this diagram is the WNA lineage (A.Br.WNA), 
which forms a branch and a node part way along this branch. 
CanSNP typing both by traditional sequencing and by the 
mass spectrometry resequencing technique of the 2 posi-
tions (10) that deﬁ  ne the WNA lineage (A.Br.WNA) and 
a branch point designated A.Br.008/009 (canSNPs in red; 
A.Br.008, and A.Br.009, respectively; Figure) conﬁ  rms 
that the Sverdlovsk sample 7.RA93.15.15 (Table) is related 
to the WNA lineage. However, the canSNP genotype of 
the Sverdlovsk sample indicates that although it may share 
a common ancestor with the WNA lineage, it is a member 
of the A Branch.008/009 subgroup that comprises isolates 
(n = 154) that were recovered primarily from Europe and 
portions of Asia (10). The close relationship between the 
WNA sublineage and this major European/Asian subgroup 
is consistent with the hypothesis that B. anthracis was in-
troduced into the North American continent by European 
settlers, possibly from France or Spain (10,12).
The early vrrA and pagA gene studies on Sverdlovsk 
tissue samples suggested that they contained multiple 
strains of B. anthracis because several vrrA alleles and pagA 
genotypes were noted. However, a dominant vrrA allele (4 
repeats), as measured by both the quantity and the quality 
of the PCR products, was found in 9 of 13 samples from 
the tissue specimens (3). In some samples, it was the only 
allele present. Similarly, the pagA diversity group V signal 
(pagA SNP 5 at bp 3602 or bp 1791 from the ATG start) 
for the WNA subgroup appeared in 7 of 10 samples of the 
Sverdlovsk tissues (5). Sverdlovsk sample 7.RA93.15.15 
contained these dominant allele signals, which suggests 
that these signals represent a single, speciﬁ  c strain of this 
pathogen.
In addition to the analysis of the canSNPs that deﬁ  ne the 
A.Br.008/009 sublineage, large portions of the pagA gene 
sequence were reconstructed from sample 7.RA93.15.15 
by using 40 overlapping PCR fragments without whole 
genome ampliﬁ  cation. The reconstruction of this gene as 
well as other loci was not always feasible for many of the 
remaining Sverdlovsk samples because of limited DNA. 
Sequence analysis of these PCR products showed a new 
A–T synonymous transversion mutation (Table) at pagA 
position bp 981, where the start ATG = bp 1, 2, 3, or posi-
tion 2784 by using the coordinates described by Price et 
al. (5). This SNP was not found in any of the original 27 
diverse B. anthracis isolates (5) or in a recent pagA gene 
sequencing analysis of 124 archival B. anthracis samples 
from the Centers for Disease Control and Prevention (13). 
The status of the new pagA 981 site was also analyzed in a 
panel of isolates containing 89 diverse multiple-locus, vari-
able-number, tandem-repeat analysis genotypes and an ad-
ditional 154 A.Br.008/009 subgroup (Eurasian) isolates by 
using a custom made real-time PCR assay: TaqMan Minor 
Groove Binding probes and primers for SSNPs (Applied 
Biosystems) (14). These analyses indicate that the pagA 
981 A–T transversion represents a rare SNP allele found in 
only 3 Eurasian isolates and the Sverdlovsk 7.RA93.15.15 
sample. (The Table shows isolates with the rare allele and a 
sampling of the additional Eurasian isolates.) This real-time 
PCR protocol is applicable to low copy–number templates 
and, somewhat, to mixed sample analyses. We applied it to 
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Figure. Schematic single nucleotide polymorphism (SNP) tree 
for Bacillus anthracis. This tree illustrates the relative positions of 
several sequenced strains of B. anthracis that form the speciﬁ  c 
sublineages in the A group of B. anthracis and in particular the 
Western North American lineage (A.BR.WNA, represented by a 
blue star [10]). The canonical SNPs and their positions are depicted 
in red lettering. A branch point (red circle) or node designated 
A.Br.008/009 originally represented 154 isolates and canSNP 
analysis places Sverdlovsk 7.RA93.15.15 in this node. The new 
pagA SNP981 deﬁ  nes a new branch radiating from this node and 
contains at least 3 other isolates.Bacillus anthracis Typing
DNA extracted from the remaining 12 Sverdlovsk tissue 
samples (3). Seven of these templates supported extensive 
ampliﬁ  cation and detected only the “T” allele at this SNP 
locus (Table) with no evidence for the alternate “A” allele.
The tissue samples with pagA 981 SNP real-time PCR 
ampliﬁ  cation were the same as samples that displayed the 
single vrrA 4-repeat signal (group V), except for 1 sample 
(40.RA93.40.5, spleen) that contained a mixture of the 
vrrA 2, 4, and 5 repeats. With this exception, a mixed signal 
could not be predicted from the previous results (3,5). Why 
a mixed signal was not seen in the latter sample is not clear, 
although multiple explanations exist, including the loss or 
curing of plasmid in certain genomes during mass culture. 
The remaining samples with multiple vrrA alleles did not 
produce amplicons in the pagA 981 real time assay.
Conclusions
CanSNP typing provides insight into a dominant 
strain involved in the 1979 Sverdlovsk anthrax out-
break and identiﬁ  es it as part of a large cluster of isolates 
(A.Br.008/009) that are found in Europe and Asia. Our 
ﬁ  ndings are consistent with claims that the weaponized 
strain released in Sverdlovsk (Anthrax 836) was origi-
nally isolated from a rodent in the city of Kirov, Soviet 
Union, in the mid-1950s (15). These ﬁ  ndings are not in 
conﬂ  ict with reports that grouped the Sverdlovsk strain 
with the WNA sublineage because this recently deﬁ  ned 
Eurasian cluster shares a common ancestor with the WNA 
isolates (7,10). Reconstruction of the pagA gene sequence 
from this Sverdlovsk sample uncovered a new SNP at po-
sition 981, which appears to be speciﬁ  c for a small subset 
of Eurasian isolates. This SNP creates a branch emanating 
from the A.Br.008/009 node and currently contains only 3 
isolates plus the prominent Sverdlovsk genotype. The ex-
tremely conserved nature of the B. anthracis genome (7), 
coupled with analysis of more than 230 close and diverse 
isolates, suggests that the pagA 981 transversion repre-
sents a new canSNP that can rapidly identify the closest 
relatives of this distinct Sverdlovsk lineage.
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A1055 C.Br.A055 T T A –pXO1
KrugerB B.Br.KrugerB T T A A
CNEVA.9066 B.Br.CNEVA T T A A
Ames A.Br.Ames T T A A
Sterne A.Br.Ames T T A A
Australia94 A.Br.Aust94 T T A A
Vollum A.Br.Vollum C T A A
(Branch point) A.Br.008/009 T G A







Western North America A.Br.WNA T G G A
A0362 Norway A.Br.008/009 T G A T
A0417 Hungary A.Br.008/009 T G A T
A0324 Slovakia A.Br.008/009 T G A T
A0293 Italy A.Br.008/009 T G AA
A0463 Pakistan A.Br.008/009 T G AA
A0149 Turkey A.Br.008/009 T G AA
A0264 Turkey A.Br.008/009 T G AA
A0032 China A.Br.008/009 T G AA
A0033 China A.Br.008/009 T G AA
A0241 Turkey A.Br.008/009 T G AA
A0245 Turkey A.Br.008/009 T G AA
A0463 Pakistan A.Br.008/009 T G AA
*This table illustrates 2 canSNPs that distinguish the subgroup/branch point A.Br.008/009 from the Western North American (WNA) sublineage. The table 
also depicts the status of the pagA 981 SNP in 7 of 12 Sverdlovsk samples and several other key isolates. Black shading, WNA lineage; gray shading, 
subgroup A.Br.008/009. Dr Okinaka is a research scientist at Northern Arizona Uni-
versity. His interests have focused on the molecular analysis 
of mutations in humans and microbial pathogens, with particu-
lar emphasis on the sequencing analysis of B. anthracis and its 
plasmids.
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